PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in BRIDGEWAY CAPITAL MANAGEMENT, LLC  ·  17 quarters on record

This page tracks every 13F SEC filing in which BRIDGEWAY CAPITAL MANAGEMENT, LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.1% (2025 Q4)
Avg. % of fund
0.02%
First filed
2021 Q4
Last filed
2025 Q4
Quarters held
17
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 773,485 +339,924 +78.4% 0.10% $4.6M $5.95
2025 Q3 ADDED 433,561 +230,771 +113.8% 0.05% $2.3M $5.31
2025 Q2 ADDED 202,790 +121,690 +150.0% 0.02% $696K $3.43
2025 Q1 REDUCED 81,100 -24,100 -22.9% 0.01% $240K $2.96
13 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to BRIDGEWAY CAPITAL MANAGEMENT, LLC Holdings